Century Therapeutics to Present at the Piper Sandler 36th Annual Healthcare Conference

Rhea-AI Summary

Century Therapeutics (NASDAQ: IPSC), a biotech company focused on iPSC-derived cell therapies for immuno-oncology and autoimmune disease, has announced its participation in the Piper Sandler 36th Annual Healthcare Conference on December 4, 2024. The company will be represented in two events: an Autoimmune Disease Cell Therapy Panel at 3:00 PM ET featuring CSO Chad Cowan, and a Fireside Chat at 4:30 PM ET with CEO Brent Pfeiffenberger and CSO Chad Cowan. A live webcast of the fireside chat will be available on the company's website with a 90-day replay option.

PHILADELPHIA, Nov. 26, 2024 (GLOBE NEWSWIRE) -- Century Therapeutics (NASDAQ: IPSC), an innovative biotechnology company developing induced pluripotent stem cell (iPSC)-derived cell therapies in immuno-oncology and autoimmune disease, today announced that members of the management team will participate in the following events at the Piper Sandler 36th Annual Healthcare Conference on Wednesday, December 4, 2024:

• Autoimmune Disease Cell Therapy Panel: 3:00 PM ET
  • Presenter: Chad Cowan, Ph.D., Chief Scientific Officer
• Fireside Chat: 4:30 PM ET
  • Presenters: Brent Pfeiffenberger, Pharm.D., Chief Executive Officer, and Chad Cowan, Ph.D., Chief Scientific Officer

A live webcast of the fireside chat can be accessed on the “Events & Presentations” page in the “Investors” section of the Company’s website at https://investors.centurytx.com/events-and-presentations. A replay of the webcast will be available for 90 days following the event.

About Century Therapeutics

Century Therapeutics (NASDAQ: IPSC) is harnessing the power of adult stem cells to develop curative cell therapy products for cancer and autoimmune diseases that we believe will allow us to overcome the limitations of first-generation cell therapies. Our genetically engineered, iPSC-derived cell product candidates are designed to specifically target hematologic and solid tumor cancers, with a broadening application to autoimmune diseases. We are leveraging our expertise in cellular reprogramming, genetic engineering, and manufacturing to develop therapies with the potential to overcome many of the challenges inherent to cell therapy and provide a significant advantage over existing cell therapy technologies. We believe our commitment to developing off-the-shelf cell therapies will expand patient access and provide an unparalleled opportunity to advance the course of cancer and autoimmune disease care. For more information on Century Therapeutics please visit www.centurytx.com.

For More Information:

Investor Relations & Media Contacts

Century Therapeutics
Katja Buhrer
SVP, Head of Corporate Affairs and Strategy
katja.buhrer@centurytx.com 
917-969-3438

Argot Partners
Noor Pahlavi
century@argotpartners.com 
212-600-1902

FAQ

When is Century Therapeutics (IPSC) presenting at the Piper Sandler Healthcare Conference 2024?

Century Therapeutics will present at the Piper Sandler Healthcare Conference on December 4, 2024, with two sessions: a panel at 3:00 PM ET and a fireside chat at 4:30 PM ET.

What events will Century Therapeutics (IPSC) participate in at the Piper Sandler Conference?

Century Therapeutics will participate in an Autoimmune Disease Cell Therapy Panel at 3:00 PM ET and a Fireside Chat at 4:30 PM ET.

How long will the Century Therapeutics (IPSC) fireside chat webcast be available?

The webcast replay will be available for 90 days following the event on Century Therapeutics' investor relations website.

Who are the presenters for Century Therapeutics (IPSC) at the Piper Sandler Conference?

The presenters are Chad Cowan, Ph.D., Chief Scientific Officer (for both events), and Brent Pfeiffenberger, Pharm.D., Chief Executive Officer (for the fireside chat).